M. Chatwin (London, United Kingdom), M. Ferrer (Barcelona, Spain)
Phenotype-genotype links and respiratory profiles in congenital muscular dystrophy (CMD) M. Chatwin, E. Clement, F. Muntoni, A. Simonds (London, United Kingdom)
| |
Congestive heart failure (CHF) and obstructive sleep apnea (OSAS) – A new frontier G. Reis, V. Fonseca, C. Alves, L. Santos, H. Almeida, M. Pinto, A. Pinto Saraiva (Barreiro, Portugal)
| |
Patient-ventilator asynchronies are not all always related to leaks during non invasive pressure support ventilation R. Naeck, D. Bounoiare, U. S. Freitas, H. Rabarimanantsoa, A. Portmann, F. Portier, C. Letellier, A. Cuvelier, J. F. Muir (St-Etienne du Rouvray, Rouen, France)
| |
Effect of different modes of NIV in neuromuscular disease G. Crescimanno, O. Marrone (Palermo, Italy)
| |
Provision of non-invasive ventilation (NIV) in the United Kingdom S. Cowman, K. Krishnan, S. Jack, J. Ball, S. Kaul (London, Wrexham, United Kingdom)
| |
Non-invasive ventilation in the emergency department versus the intensive care unit for life-threatening exacerbations of chronic obstructive pulmonary disease I. Ibrahim, J. Phua, M. Mahadevan, T. K Lim (Singapore, Singapore)
| |
What do built-in softwares in home ventilators tell us? An observational study of 150 patients on home mechanical ventilation (HMV) in Geneva P. Pasquina, P. Hintermann-Bourqui, P. Farr, D. Adler, P. O. Bridevaux, J. P. Janssens (Switzerland)
| |
Pathogenesis of daytime hypercapnia in myotonic dystrophy B. Buyse, R. Vandenberghe, D. Willekens, E. Pijkels, J. Steyaert (Leuven, Belgium)
| |
Effect of noninvasive ventilation (NIV) on exercise tolerance in patients with acute decompensated heart failure X. Popova, S. Avdeev, G. Nekludova, A. Chuchalin (Moscow, Russian Federation)
| |
Non-invasive mechanical ventilation in influenza A(H1N1)-Associated ARDS/ALI V. Bocchino, C. Calabrese, S. Ubaldi, S. Marsico, F. Squillante, M. Aliperta (Napoli, Italy)
| |
MRC dyspnoea grade, admission CRP, hours of non-invasive ventilation(NIV) administered and need for endotracheal intubation, predict 3 month outcome in patients receiving NIV for acute COPD S. D. W. Miller, R. M. West, M. W. Elliott (Leeds, United Kingdom)
| |
Quality of life in home ventilation (HMV): Validation of the English version of severe respiratory insufficiency (SRI) questionnaire D. Ghosh, P. Rzehak, M. W. Elliott, W. Windisch (Leeds, United Kingdom; Neuherberg, Germany)
| |
Longterm effects of non-invasive ventilation in hypercapnic COPD L. De Backer, W. Vos, J. De Backer, D. Daems, R. Claes, P. Germonpre, W. De Backer (Antwerp, Edegem, Belgium)
| |
Hypercapnia in myotonic dystrophy: Is there a gender difference? B. Buyse, R. Vandenberghe, D. Willekens, E. Pijkels, J. Steyaert (Leuven, Belgium)
| |
Clinical profile and characteristics of domiciliary ventilation in patients with overlap syndrome (COPD+OSAS) F. Lavergne, A. S. Bravard, L. C. Molano, F. Portier, J. F. Muir, A. Cuvelier (Paris, France)
| |
Predictive factors of hypoventilation during amyotrophic lateral sclerosis (ALS) E. Barbare, C. Tardif, D. Hannequin, J. F. Muir, A. Cuvelier (France)
| |
Early experience with home transcutaneous CO2 monitoring (TcCO2/SpO2) in the setting of a domiciliary assisted ventilation service C. A. O‘Dowd, A. Clarke, D. McFarlane, S. Banham (Glasgow, United Kingdom)
| |
The safety and efficacy of nasal continuous positive airways pressure (CPAP) in acute bronchiolitis C. Kallappa, A. Kannivelu, J. Alexander, T. Ninan (Stoke on Trent, Birmingham, United Kingdom)
| |